A chemoenzymatic approach providing access to all four intermediates in the peppermint biosynthetic pathway between limonene and menthone/isomenthone, including noncommercially available intermediates (−)-trans-isopiperitenol (2), (−)-isopiperitenone (3), and (+)-cis-isopulegone (4), is described. Oxidation of (+)-isopulegol (13) followed by enolate selenation and oxidative elimination steps provides (−)-isopiperitenone (3). A chemical reduction and separation route from (3) provides both native (−)-trans-isopiperitenol (2) and isomer (−)-cis-isopiperitenol (18), while enzymatic conjugate reduction of (−)-isopiperitenone (3) with IPR [(−)-isopiperitenone reductase)] provides (+)-cis-isopulegone (4). This undergoes facile base-mediated chemical epimerization to (+)-pulegone (5), which is subsequently shown to be a substrate for NtDBR (Nicotiana tabacum double-bond reductase) to afford (−)-menthone (7) and (+)-isomenthone (8).
Mammalian cells orchestrate signalling through interaction events on their surfaces. Proteoglycans are an intricate part of these interactions, carrying large glycosaminoglycan polysaccharides that recruit signalling molecules. Despite their importance in development, cancer and neurobiology, a relatively small number of proteoglycans have been identified. In addition to the complexity of glycan extension, biosynthetic redundancy in the first protein glycosylation step by two xylosyltransferase isoenzymes XT1 and XT2 complicates annotation of proteoglycans. Here, we develop a chemical genetic strategy that manipulates the glycan attachment site of cellular proteoglycans. By employing a tactic termed bump- and-hole engineering, we engineer the two isoenzymes XT1 and XT2 to specifically transfer a chemically modified xylose analogue to target proteins. The chemical modification contains a bioorthogonal tag, allowing the ability to visualise and profile target proteins modified by both transferases in mammalian cells. The versatility of our approach allows pinpointing glycosylation sites by tandem mass spectrometry, and exploiting the chemical handle to manufacture proteoglycans with defined GAG chains for cellular applications. Engineered XT enzymes permit a view into proteoglycan biology that is orthogonal to conventional techniques in biochemistry.
As the world moves towards net‐zero carbon emissions, the development of sustainable chemical manufacturing processes is essential. Within manufacturing, purification by distillation is often used, however this process is energy intensive and methods that could obviate or reduce its use are desirable. Developed herein is an alternative, oxidative biocatalytic approach that enables purification of alkyl monoglucosides (essential bio‐based surfactant components). Implementing an immobilised engineered alcohol oxidase, a long‐chain alcohol by‐product derived from alkyl monoglucoside synthesis (normally removed by distillation) is selectively oxidised to an aldehyde, conjugated to an amine resin and then removed by simple filtration. This affords recovery of the purified alkyl monoglucoside. The approach lays a blueprint for further development of sustainable alkylglycoside purification using biocatalysis and, importantly, for refining other important chemical feedstocks that currently rely on distillation.
<!----> <!----> Oligomannosides are common constituents of plant, invertebrate, and vertebrate N-glycoproteins such as in high mannose-, hybrid-, paucimannosidic-, and complex-type glycans but also occur as antigenic determinants in the viral glycan shield of HIV 1. 1–3 Furthermore, α-mannosides are frequently found components of bacterial and fungal polysaccharides. 4–5 Glycosylation reactions leading to α-mannosides are well developed, but there is still a need to improve the assembly of oligomannosides with respect to scalability, ease of purification, and simplification of protecting group patterns. 6 <!----> <!---->